Carrada BT

Language: Spanish
References: 15
Page: 256-260
PDF size: 442.94 Kb.

ABSTRACT

Mucormycosis is an opportunistic fungal infection, it affects decompensated diabetics, immunosupressed patients and occasionally healthy persons. Despite advances in anti-fungal therapy and surgical techniques the mortality remains high. A clinical-radiologic case of rhino-ocular mucormycosis, recorded in a diabetic woman is presented, the histopathology and the mycologic study of a Rhizopus spp strain isolated by culture of the necrotic facial tissue. The patient was treated with amphotericin B intravenous, total dose 2,800 mg, for 25 days, surgical debridement which included enucleation of the right eye end resection of paranasal sinuses. The diagnostic protocol and therapeutic management of mucormycosis was reviewed.

REFERENCES

1. Romero-Zamora JL, Bonifaz A, Sánchez CJ, Lagunas-Ramírez A, Hidalgo-Loperena H. Mucormicosis rinocerebral. Reporte de doce casos. Rev Med Hosp Gen (Mex) 2000;63:178-84.

2. Butugan O, Sánchez T, González F, Venosa A, et al. Rhinocerebral mucormycosis: predisposing factors, diagnosis, therapy, complications and survival. Rev Laryngol Otol Rhinol 1996;117:53-55.

3. Gokhale YA, Ramnath A, Patil RD, Prasar S, et al. Rhinocerebral mucormycosis associated with diabetic ketoacidosis. J Assoc Physicians India 1991;39:970-1.

4. Sugar AM. Agentes de la mucormicosis y especies relacionadas. En: Mandell Gl, Bennett JE, Dolin R, editores. Enfermedades infecciosas. Principios y prácticas. 4a ed. Buenos Aires: Médica Panamericana, 1997:pp:595-2606.

5. Case Records of the Massachussets General Hospital. Mucormycosis, rhino-orbital. N Engl J Med 2002;346:924-9.

6. Abramson E, Wilson D, Arky RA. Rhinocerebral phycomycosis in association with diabetic ketoacidosis: report of two cases and a review of clinical and experimental experience with amphotericin-B therapy. Ann Intern Med 1967;66:735-42.

7. Bachor R, Baczako K, Kern W. Isolierte cerebrale mucormycose bei leukamie. Mykosen 1986;29:497-501.

8. Boelaert JR, Vergauwe PL, Vandepitte JM. Mucormycosis infection in dialysis patients. Ann Intern Med 1987;107:782-3.

9. Abe F, Inaba H, Kath T, Hotchi M. Effects of iron and desferoxamine on Rhizopus infection. Mycopathologia 1990;110:87-91.

10. Veis JH, Contiguglia R, Kein M, Mishell J, et al. Mucormycosis in deferoxamine treated patiens on dialysis. Ann Intern Med 1987;107:258-9.

11. Torres-Rodrígez JM. Micosis sistémicas. Monografías clínicas en enfermedades infecciosas núm. 5. Barcelona: Doyma, 1991;pp:75-80.

12. Carrada Bravo T. Mucormicosis rinorbital en un paciente con sídrome de inmudeficiencia adquirida. Rev Mex Oftalmol 2004;78:193-5.

13. Cervantes-Apolinar Y, Peña-Alonso R, Tanaka-Kido J. Mucormicosis neonatal ¿nosocomial? Informe de un caso y revisión de la literatura. Bol Med Hosp Infant Mex 1996;53:568-74.

14. Yohai RA, Bullock JD, Aziz AA, Markert RJ. Survival factors in rhino-orbital cerebral mucormycosis. Surv Ophthalmol 1994;39:3-22.

15. Galetta SL, Wulc AE, Goldberg HI, Nichols CW, et al. Rhinocerebral mucormycosis: management and survival after carotid artery oclusion. Ann Neurol 1990;28:103-7.